Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABCG8-mediated sterol efflux increases cancer cell progression through LRP6/Wnt/beta-catenin signaling pathway in radiotherapy-resistant triple negative breast cancer cells (RT-R-TNBC), RT-R-MDA-MB-231

ABSTRACT: ABCG8-mediated sterol efflux increases cancer cell progression through LRP6/Wnt/beta-catenin signaling pathway in radiotherapy-resistant triple negative breast cancer cells (RT-R-TNBC), RT-R-MDA-MB-231

PROVIDER: PRJNA1214855 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR32098939.fastq.gz	Fastqsanger.gz
	SRR32098940.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

ABCG8-mediated sterol efflux increases cancer cell progression through LRP6/Wnt/beta-catenin signaling pathway in radiotherapy-resistant triple negative breast cancer cells (RT-R-TNBC), RT-R-MDA-MB-231

Project description:ATP-binding cassette (ABC) transporters are known to be increased in various tumor cells, including breast cancer. They are responsible for mediating drug resistance, leading to treatment failure. In the present study, gene expression array analysis revealed that among ABC transporter subtypes, ABCG8 was most increased in radiotherapy-resistant triple negative breast cancer (RT-R-TNBC) compared to TNBC. ABCG8 is known to be involved in sterol efflux, but its role in cancer is not well known. Therefore, we investigated the effect of ABCG8 on tumor progression in RT-R-TNBC. RT-R-MDA-MB-231 exhibited increased cholesterol levels in both cells and surrounding media by inducing SREBP1 and FASN. ABCG8 siRNA increased intracellular cholesterol but decreased media cholesterol, indicating an accumulation of cholesterol inside cells. Additionally, RT-R-MDA-MB-231 showed increased levels of β-catenin, which was significantly reduced by ABCG8 knockdown. Moreover, ABCG8 knockdown led to cell cycle arrest in the G2/M phase by reducing PLK1 and Cyclin B1. RT-R-MDA-MB-231 also exhibited increased phosphor-LRP6 and LRP6 levels, which were decreased by ABCG8 siRNA. Interestingly, LRP6 siRNA decreased β-catenin, PLK1, and Cyclin B1. In addition, feedback mechanisms such as LXR and IDOL were decreased in RT-R-MDA-MB-231 cells. This study suggests for the first time the role of ABCG8 and the cholesterol exported by ABCG8, not inside the cells, affects cancer progression through the LRP6/Wnt/beta-catenin signaling pathway in RT-R-TNBC. The regulation of this pathway may offer a potential therapeutic strategy for treating RT-R-TNBC.

2025-02-01 | GSE287883 | GEO

Copper acts synergistically with fluconazole in Candida glabrata by compromising drug efflux, zinc homeostasis and sterol metabolism

Project description:In this study we used a transcriptomic approach to study the molecular determinants of the synergy between copper and fluconazole, in Candida glabrata, the second most frequent cause of invasive candidiasis. We demonstrate that copper acts together with fluconazole by downregulating three distinct pathways: azole efflux, ergosterol biosynthesis and zinc homeostasis. Coincidently, all these pathways are important for C. glabrata to cope with fluconazole stress. Therefore, when copper and fluconazole are combined cells fail to detoxify this drug and accumulate toxic methylated intermediates of sterol metabolism. This accumulation, possibly together with copper-induced lipid damages, should affect the activity of plasma membrane transporters, which impedes zinc uptake, leading to zinc depletion

2022-06-01 | GSE162741 | GEO

Transcriptome analysis of LRP5- and LRP6-depleted HCC38 cells.

Project description:In order to characterize the differences between the co-receptors LRP5 and LRP6, we have analyzed the transcriptome of HCC38 cells - a triple negative breast cancer cell line - 24, 48 and 72 hours following the depletion of LRP5 or LRP6 using siRNAs.

2018-06-06 | GSE109004 | GEO

Pharmaceutical reversal of Dkk1-induced LRP6 endocytosis prevents cancer cachexia and prolongs survival

Project description:Cancer cachexia with profound weight loss and frailty impairs quality of life, limits cancer therapy and decreases survival, against which no effective therapy is available. Dkk1 is a secreted antagonist of Wnt/β-catenin pathway via interacting with Wnt co-receptors LRP5 and 6 (LRP5/6) and inducing their endocytosis1-4. Although Dkk1 is critical for animal development3,5, its mRNA is undetectable in most adult organs6. Of note, elevated circulating Dkk1 leads to poor prognosis in patients with a variety of types of cancer by a completely unknown mechanism. Here, we show that administration of a recombinant Dkk1 protein accelerated cancer cachexia-related death through inducing LRP6 endocytosis but not β-catenin inhibition, whereas pharmacological blockade of Dkk1-induced membrane LRP6 downregulation completely prevented cancer cachexia and robustly prolonged survival in tumor-bearing mice. Pharmacological blockade of Dkk1-induced membrane LRP6 downregulation prevented alterations of a number of GPCR pathways and all main cancer cachexia-related pathways in skeletal muscle of mice bearing tumor as shown by a genome-wide transcriptional analysis. Furthermore, Dkk1 injection into hindlimb directly triggered activations of GPCR pathways and cachexia-related pathways. These findings establish a key role of the Dkk1-LRP6 axis in cancer cachexia development through affecting GPCR pathways and suggest a highly promising therapeutic approach for preventing cancer cachexia.

2024-12-01 | GSE121873 | GEO

Sequencing facilitates quantitative analysis of transcriptomes in wild type and Lrp6-knockdown cells

Project description:Purpose: The goals of this study are to determine the LRP6-mediated splicing regulation, and cellular transcriptomes from rat and human are analysised by deep sequencing. Methods: The mRNA profiles of WT and LRP6 KD were generated by deep sequencing, using Illumina HiSeq 4000. And the transcript isoform difference betwwen the two group were analysied by bioinformation, Semiquantitative PCR was performed to identify the analysis result. Results and conclusions: We detected a substantial number of Lrp6 loss-induced AS events, and up to nearly 50 of them were exon-skipped. A gene ontology analysis of the conserved LRP6-driven network showed enrichment for ninety-four genes encoding proteins mainly involved in cellular and metabolic processes . Among them, a decade of genes with LRP6-dependent isoform expression showed identical splicing patterns on the exon level across species. The RNA sequencing results were further verified by Semiquantitative PCR. We conclude that LRP6 could regulate mRNA splicing.

2018-08-20 | GSE102770 | GEO

Copper acts synergistically with fluconazole in Candida glabrata by compromising drug efflux, zinc homeostasis and sterol metabolism

Project description:Copper acts synergistically with fluconazole in Candida glabrata by compromising drug efflux, zinc homeostasis and sterol metabolism

| PRJNA682828 | ENA

Project description:Drosophila melanogaster rt, rotated abdomen, is differentially expressed in 15 experiment(s);

| FBgn0003292 | ExpressionAtlas

Project description:Drosophila melanogaster rt, rotated abdomen, is expressed in 4 baseline experiment(s);

| FBgn0003292 | ExpressionAtlas

Transcriptomic sterol response in the HepG2 human hepatoma cell line

Project description:Statins are cholesterol lowering drugs that inhibit cholesterol synthesis and reduce intracellular sterol levels, stimulating a transcriptional response. We sought to identify genes that were statin responsive in the HepG2 human hepatoma cell line and determine which of those genes were sterol responsive using sterol addback conditions. Though the vast majority of statin responsive genes are sterol responsive, we identified a subset of statin responsive genes whose gene expression changes are not reversed upon sterol addback.

2024-12-10 | GSE190736 | GEO

Sterol-degrading bacteria

Project description:Genome analysis of sterol-degrading bacteria isolated from marine sponges

| PRJEB30766 | ENA